Prolactin protects against the methamphetamine-induced cerebral vascular toxicity

Current Neurovascular Research

Volumn 10, Issue 4, 2013, Pages 346-355

  Rosas Hernandez, Hector ^a,b   Cuevas, Elvis ^b   Lantz, Susan M ^b   Peak, M ^b   Ali, Syed F ^b   Gonzalez, Carmen ^a  

^a UNIVERSIDAD AUTÓNOMA DE SAN LUIS POTOSÍ   (Mexico)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

Author keywords

Blood brain barrier; Brain endothelial cells; Methamphetamine; Prolactin; Tight junctions; Trans endothelial electrical resistance

Indexed keywords

CLAUDIN 5; GELATINASE B; METHAMPHETAMINE; OCCLUDIN; PROLACTIN; TIGHT JUNCTION PROTEIN;

ANIMAL CELL; APOPTOSIS; ARTICLE; BLOOD BRAIN BARRIER; CELL PROLIFERATION; CONTROLLED STUDY; ELECTRIC RESISTANCE; ENDOTHELIUM CELL; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; APOPTOSIS; BLOOD-BRAIN BARRIER; BLOTTING, WESTERN; CAPILLARY PERMEABILITY; CATTLE; CELL PROLIFERATION; CENTRAL NERVOUS SYSTEM STIMULANTS; ENDOTHELIAL CELLS; METHAMPHETAMINE; PROLACTIN; TIGHT JUNCTION PROTEINS; TIGHT JUNCTIONS;

EID: 84888213023     PISSN: 15672026     EISSN: 18755739     Source Type: Journal    
DOI: 10.2174/15672026113109990031     Document Type: Article

References (47)

1. United Nations Office on Drugs and Crime. World Drug Report. UN Publication. 2010. Sales No. E.10.XI.1.
2. Cruickshank CC, Dyer KR. A review of the clinical pharmacology of methamphetamine. Addiction. 2009;104(7):1085-99.
3. Thrash B, Karuppagounder SS, Uthayathas S, Suppiramaniam V, Dhanasekaran M. Neurotoxic effects of methamphetamine. Neurochem Res. 2010;35(1):171-9.
4. Goodwin JS, Larson GA, Swant J, et al. Amphetamine and methamphetamine differentially affect dopamine transporters in vitro and in vivo. J Biol Chem. 2009;284(5):2978-89.
5. Bernacki J, Dobrowolska A, Nierwinska K, Malecki A. Physiology and pharmacological role of the blood-brain barrier. Pharmacol Rep. 2008;60(5):600-22.
6. Cardoso FL, Brites D, Brito MA. Looking at the blood-brain barrier: molecular anatomy and possible investigation approaches. Brain Res Rev. 2010;64(2):328-63.
7. Piontek J, Winkler L, Wolburg H, et al. Formation of tight junction: determinants of homophilic interaction between classic claudins. FASEB J. 2008;22(1):146-58.
8. Redzic Z. Molecular biology of the blood-brain and the bloodcerebrospinal fluid barriers: similarities and differences. Fluids Barriers CNS. 2011;8(1):3.
9. Sharma HS, Ali SF. Alterations in blood-brain barrier function by morphine and methamphetamine. Ann N Y Acad Sci. 2006;1074:198-224.
10. Bowyer JF, Ali S. High doses of methamphetamine that cause disruption of the blood-brain barrier in limbic regions produce extensive neuronal degeneration in mouse hippocampus. Synapse. 2006;60(7):521-32.
11. Ramirez SH, Potula R, Fan S, et al. Methamphetamine disrupts blood-brain barrier function by induction of oxidative stress in brain endothelial cells. J Cereb Blood Flow Metab. 2009;29(12):1933-45.
12. Zhang X, Banerjee A, Banks WA, Ercal N. N-Acetylcysteine amide protects against methamphetamine-induced oxidative stress and neurotoxicity in immortalized human brain endothelial cells. Brain Res. 2009;1275:87-95.
13. Park M, Hennig B, Toborek M. Methamphetamine alters occludin expression via NADPH oxidase-induced oxidative insult and intact caveolae. J Cell Mol Med. 2012;16(2):362-75.
14. Martins T, Burgoyne T, Kenny BA, et al. Methamphetamineinduced nitric oxide promotes vesicular transport in blood-brain barrier endothelial cells. Neuropharmacology. 2013;65:74-82.
15. Martins T, Baptista S, Goncalves J, et al. Methamphetamine transiently increases the blood-brain barrier permeability in the hippocampus: role of tight junction proteins and matrix metalloproteinase-9. Brain Res. 2011;1411:28-40.
16. Northrop NA, Yamamoto BK. Persistent neuroinflammatory effects of serial exposure to stress and methamphetamine on the blood-brain barrier. J Neuroimmune Pharmacol. 2012;7(4):951-68.
17. Zorick T, Mandelkern MA, Lee B, et al. Elevated plasma prolactin in abstinent methamphetamine-dependent subjects. Am J Drug Alcohol Abuse. 2011;37(1):62-7.
18. Murnane KS, Kimmel HL, Rice KC, Howell LL. The neuropharmacology of prolactin secretion elicited by 3,4-methylenedioxymethamphetamine ("ecstasy"): a concurrent microdialysis and plasma analysis study. Horm Behav. 2012;61(2):181-90.
19. Freeman ME, Kanyicska B, Lerant A, Nagy G. Prolactin: structure, function, and regulation of secretion. Physiol Rev. 2000;80(4):1523-631.
20. Castilla A, Garcia C, Cruz-Soto M, Martinez de la Escalera G, Thebault S, Clapp C. Prolactin in ovarian follicular fluid stimulates endothelial cell proliferation. J Vasc Res. 2010;47(1):45-53.
21. Reuwer AQ, Nowak-Sliwinska P, Mans LA, et al. Functional consequences of prolactin signalling in endothelial cells: a potential link with angiogenesis in pathophysiology? J Cell Mol Med. 2012;16(9):2035-48.
22. Malaguarnera L, Pilastro MR, Quan S, et al. Significance of heme oxygenase in prolactin-mediated cell proliferation and angiogenesis in human endothelial cells. Int J Mol Med. 2002;10(4):433-40.
23. Ochoa A, Montes de Oca P, Rivera JC, et al. Expression of prolactin gene and secretion of prolactin by rat retinal capillary endothelial cells. Invest Ophthalmol Vis Sci. 2001;42(7):1639-45.
24. Linzell JL, Peaker M, Taylor JC. The effects of prolactin and oxytocin on milk secretion and on the permeability of the mammary epithelium in the rabbit. J Physiol. 1975;253(2):547-63.
25. Flint DJ, Gardner M. Evidence that growth hormone stimulates milk synthesis by direct action on the mammary gland and that prolactin exerts effects on milk secretion by maintenance of mammary deoxyribonucleic acid content and tight junction status. Endocrinology. 1994;135(3):1119-24.
26. Nguyen DA, Parlow AF, Neville MC. Hormonal regulation of tight junction closure in the mouse mammary epithelium during the transition from pregnancy to lactation. J Endocrinol. 2001;170(2):347-56.
27. Rosas-Hernandez H, Cuevas E, Lantz SM, et al. Prolactin and Blood Brain Barrier Permeability. Curr Neurovasc Res. 10:4. 7 August 2013. Available from: http://www.eurekaselect.com/114263/article.
28. Ueda EK, Huang K, Nguyen V, Ferreira M, Andre S, Walker AM. Distribution of prolactin receptors suggests an intraductal role for prolactin in the mouse and human mammary gland, a finding supported by analysis of signaling in polarized monolayer cultures. Cell Tissue Res. 2011;346(2):175-89.
29. Stelwagen K, McFadden HA, Demmer J. Prolactin, alone or in combination with glucocorticoids, enhances tight junction formation and expression of the tight junction protein occludin in mammary cells. Mol Cell Endocrinol. 1999;156(1-2):55-61.
30. Peixoto EB, Collares-Buzato CB. Modulation of the epithelial barrier by dexamethasone and prolactin in cultured Madin-Darby canine kidney (MDCK) cells. Cell Biol Int. 2006;30(2):101-13.
31. Trickler WJ, Lantz SM, Murdock RC, et al. Silver nanoparticle induced blood-brain barrier inflammation and increased permeability in primary rat brain microvessel endothelial cells. Toxicol Sci. 2010;118(1):160-70.
32. Chen H, Wu J, Zhang J, et al. Protective effects of the antioxidant sulforaphane on behavioral changes and neurotoxicity in mice after the administration of methamphetamine. Psychopharmacology (Berl). 2012;222(1):37-45.
33. Afanador L, Mexhitaj I, Diaz C, Ordonez D, Baker L, Angulo JA. The role of the neuropeptide somatostatin on methamphetamine and glutamate-induced neurotoxicity in the striatum of mice. Brain Res. 2013;1510:38-47.
34. da Silva DD, Silva E, Carmo H. Combination effects of amphetamines under hyperthermia-the role played by oxidative stress. J Appl Toxicol. 13 Jun 2013. Available from: http://onlinelibrary.wiley.com/doi/10.1002/jat.2889/full
35. Zhang X, Tobwala S, Ercal N. N-acetylcysteine amide protects against methamphetamine-induced tissue damage in CD-1 mice. Hum Exp Toxicol. 2012;31(9):931-44.
36. Barayuga SM, Pang X, Andres MA, Panee J, Bellinger FP. Methamphetamine decreases levels of glutathione peroxidases 1 and 4 in SH-SY5Y neuronal cells: protective effects of selenium. Neurotoxicology. 2013;37:240-6.
37. Parameyong A, Charngkaew K, Govitrapong P, Chetsawang B. Melatonin attenuates methamphetamine-induced disturbances in mitochondrial dynamics and degeneration in neuroblastoma SHSY5Y cells. J Pineal Res. 27 Jul 2013. Available from: http://onlinelibrary.wiley.com/doi/10.1111/jpi.12078/full
38. Shiba T, Yamato M, Kudo W, Watanabe T, Utsumi H, Yamada K. In vivo imaging of mitochondrial function in methamphetamine treated rats. Neuroimage. 2011;57(3):866-72.
39. Zhu JP, Xu W, Angulo JA. Distinct mechanisms mediating methamphetamine-induced neuronal apoptosis and dopamine terminal damage share the neuropeptide substance p in the striatum of mice. Ann N Y Acad Sci. 2006;1074:135-48.
40. Kanthasamy A, Anantharam V, Ali SF, Kanthasamy AG. Methamphetamine induces autophagy and apoptosis in a mesencephalic dopaminergic neuronal culture model: role of cathepsin-D in methamphetamine-induced apoptotic cell death. Ann N Y Acad Sci. 2006;1074:234-44.
41. Kanthasamy K, Gordon R, Jin H, Anantharam V, Ali S, Kanthasamy AG, et al. Neuroprotective effect of resveratrol against methamphetamine-induced dopaminergic apoptotic cell death in a cell culture model of neurotoxicity. Curr Neuropharmacol. 2011;9(1):49-53.
42. Shao X, Hu Z, Hu C, et al. Taurine protects methamphetamineinduced developmental angiogenesis defect through antioxidant mechanism. Toxicol Appl Pharmacol. 2012;260(3):260-70.
43. Yang Y, Estrada EY, Thompson JF, Liu W, Rosenberg GA. Matrix metalloproteinase-mediated disruption of tight junction proteins in cerebral vessels is reversed by synthetic matrix metalloproteinase inhibitor in focal ischemia in rat. J Cereb Blood Flow Metab. 2007;27(4):697-709.
44. Feng S, Cen J, Huang Y, et al. Matrix metalloproteinase-2 and-9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins. PLoS One. 2011;6(8):e20599.
45. Dluzen DE, Anderson LI, Pilati CF. Methamphetamine-gonadal steroid hormonal interactions: effects upon acute toxicity and striatal dopamine concentrations. Neurotoxicol Teratol. 2002;24(2):267-73.
46. Gajjar TM, Anderson LI, Dluzen DE. Acute effects of estrogen upon methamphetamine induced neurotoxicity of the nigrostriatal dopaminergic system. J Neural Transm. 2003;110(11):1215-24.
47. Gonzalez C, Parra A, Ramirez-Peredo J, et al. Elevated vasoinhibins may contribute to endothelial cell dysfunction and low birth weight in preeclampsia. Lab Invest. 2007;87(10):1009-17.